CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure SPECT and PET in ischemic heart failure Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Best Practices for the Prevention of Radial Artery Occlusion After Transradial Diagnostic Angiography and Intervention An International Consensus Paper Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years Heart failure with preserved ejection fraction: from mechanisms to therapies

Clinical Trial2018 Oct 22;17(1):137.

JOURNAL:Cardiovasc Diabetol. Article Link

Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate

Sardu C, Paolisso P, Sacra C et al. Keywords: cardiac resynchronization therapy with defibrillator; diabetes mellitus; arrhythmic burden; heart failure

FULL TEXT PDF